The antioxidant in the oriental drug, NP-S, traditionally used as a therapeutic agent for Hepatitis B was identified. The NP-S was divided into two fractions at molecular weight cut-off of 1000 by ultrafiltration and the fraction having molecular weight less than 1000 was named as NP-S(l)10. Both NP-S and NP-S(l)10 had antioxidant activity. An antioxidant that was extracted by chloroform from water-insoluble fraction in lyophilized NP-S(l)10 had a little smaller activity than NP-S(l)10 and identified as cyclooctasulfur(S8) by mass spectrum.
Keywords: Hepatitis B, antioxidant, cyclooctasulfur
Mi Jeong Choi and Yu Ri Kim
Microbiol. Biotechnol. Lett. 2024; 52(1): 65-75 https://doi.org/10.48022/mbl.2401.01007Mi Jeong Choi and Yu Ri Kim
Microbiol. Biotechnol. Lett. 2024; 52(1): 55-64 https://doi.org/10.48022/mbl.2401.01012DanHee Yoo and InChul Lee
Microbiol. Biotechnol. Lett. 2024; 52(1): 15-23 https://doi.org/10.48022/mbl.2311.11012